D

DNA Chip Research Inc
TSE:2397

Watchlist Manager
DNA Chip Research Inc
TSE:2397
Watchlist
Price: 999 999.9999 JPY Market Closed
Market Cap: ¥7.4B

Operating Margin

3.6%
Current
Improving
by 56.4%
vs 3-y average of -52.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
3.6%
=
Operating Income
¥39.7m
/
Revenue
¥1.1B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
3.6%
=
Operating Income
¥39.7m
/
Revenue
¥1.1B

Peer Comparison

Country Company Market Cap Operating
Margin
JP
DNA Chip Research Inc
TSE:2397
7.4B JPY
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
238.1B USD
Loading...
US
Danaher Corp
NYSE:DHR
167.3B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
83.6T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.8B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.5B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
277.8B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.4B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.1B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

Lower than 73% of companies in Japan
Percentile
27th
Based on 6 730 companies
27th percentile
3.6%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

DNA Chip Research Inc
Glance View

DNA Chip Research, Inc. engages in the business of contract analysis and Deoxyribonucleic Acid (DNA) chip technology development services. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 29 full-time employees. The company went IPO on 2004-03-18. The Contract Research segment is engaged in the microarray, next-generation sequencing experiment analysis to universities and research institutes, pharmaceutical and food companies. The Diagnostic segemnt utilizes genetic analysis technology to disseminate tests corresponding to social needs on personalized medicine and undiseased society. The main menu of the diagnostic business is EGFR-NGS Check. The Research and Development segment includes research on cancer diagnosis technology using next generation sequencer, as well as the development of RNA check.

Intrinsic Value
248 921.2584 JPY
Overvaluation 75%
Intrinsic Value
Price
D
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
3.6%
=
Operating Income
¥39.7m
/
Revenue
¥1.1B
What is DNA Chip Research Inc's current Operating Margin?

The current Operating Margin for DNA Chip Research Inc is 3.6%, which is above its 3-year median of -52.7%.

How has Operating Margin changed over time?

Over the last 3 years, DNA Chip Research Inc’s Operating Margin has increased from -38.9% to 3.6%. During this period, it reached a low of -110.8% on Mar 31, 2023 and a high of 3.6% on May 1, 2025.

Back to Top